Haemonetics Corporation (NYSE:HAE - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eleven research firms that are currently covering the company, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating, six have assigned a buy rating an